BID and hepatocellular carcinoma: Pretreatment with TSA alone or TSA in combination with etoposide, a stabilizer for DSB, significantly sensitized HCC cells to apoptosis via inhibiting ERK phosphorylation, reactivating caspases and PARP, and inducing translocation of p53 and Bid to cytoplasm [205].